Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabarun Chandra Das

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Genetics|February 18, 2021
Exploring the Differential Expression and Prognostic Significance of the COL11A1 Gene in Human Colorectal Carcinoma: An Integrated Bioinformatics ApproachRitwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee
Advances in Experimental Medicine and Biology|February 8, 2022
Toll-Like Receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological PerspectiveRitwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee
Journal of Medical Virology|January 6, 2021
In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humansAbhigyan Choudhury, Nabarun Chandra Das, Ritwik Patra, et al.
Antibodies (Basel, Switzerland)|March 28, 2023
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An <i>In Silico</i> InvestigationNabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, et al.
Frontiers in Immunology|January 27, 2022
<i>In Silico</i> Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike ProteinNabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, et al.
Antibodies (Basel, Switzerland)|April 30, 2021
Therapeutic Efficacy of Anti-Bestrophin Antibodies against Experimental Filariasis: Immunological, Immune-Informatics and Immune Simulation InvestigationsNabarun Chandra Das, Anindya Sundar Ray, Jagadeesh Bayry, et al.
Future Virology|July 11, 2022
Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an <i>in silico</i> studyBhabani Shankar Das, Nabarun Chandra Das, Shasank Sekhar Swain, et al.
Journal of Cellular and Molecular Medicine|August 22, 2023
Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findingsNabarun Chandra Das, Pritha Chakraborty, Samapika Nandy, et al.
International Immunopharmacology|December 31, 2022
Reverse vaccinology assisted design of a novel multi-epitope vaccine to target Wuchereria bancrofti cystatin: An immunoinformatics approachNabarun Chandra Das, Parth Sarthi Sen Gupta, Saroj Kumar Panda, et al.
Journal of Biomolecular Structure & Dynamics|May 6, 2021
<i>In-silico</i> evidences on filarial cystatin as a putative ligand of human TLR4Nabarun Chandra Das, Parth Sarthi Sen Gupta, Satyaranjan Biswal, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Genetics|February 18, 2021
Exploring the Differential Expression and Prognostic Significance of the COL11A1 Gene in Human Colorectal Carcinoma: An Integrated Bioinformatics ApproachRitwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee
Advances in Experimental Medicine and Biology|February 8, 2022
Toll-Like Receptors (TLRs) as Therapeutic Targets for Treating SARS-CoV-2: An Immunobiological PerspectiveRitwik Patra, Nabarun Chandra Das, Suprabhat Mukherjee
Journal of Medical Virology|January 6, 2021
In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of humansAbhigyan Choudhury, Nabarun Chandra Das, Ritwik Patra, et al.
Antibodies (Basel, Switzerland)|March 28, 2023
Comparative Binding Ability of Human Monoclonal Antibodies against Omicron Variants of SARS-CoV-2: An <i>In Silico</i> InvestigationNabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, et al.
Frontiers in Immunology|January 27, 2022
<i>In Silico</i> Analyses on the Comparative Potential of Therapeutic Human Monoclonal Antibodies Against Newly Emerged SARS-CoV-2 Variants Bearing Mutant Spike ProteinNabarun Chandra Das, Pritha Chakraborty, Jagadeesh Bayry, et al.
Antibodies (Basel, Switzerland)|April 30, 2021
Therapeutic Efficacy of Anti-Bestrophin Antibodies against Experimental Filariasis: Immunological, Immune-Informatics and Immune Simulation InvestigationsNabarun Chandra Das, Anindya Sundar Ray, Jagadeesh Bayry, et al.
Future Virology|July 11, 2022
Andrographolide induces anti-SARS-CoV-2 response through host-directed mechanism: an <i>in silico</i> studyBhabani Shankar Das, Nabarun Chandra Das, Shasank Sekhar Swain, et al.
Journal of Cellular and Molecular Medicine|August 22, 2023
Programmed cell death pathways as targets for developing antifilarial drugs: Lessons from the recent findingsNabarun Chandra Das, Pritha Chakraborty, Samapika Nandy, et al.
International Immunopharmacology|December 31, 2022
Reverse vaccinology assisted design of a novel multi-epitope vaccine to target Wuchereria bancrofti cystatin: An immunoinformatics approachNabarun Chandra Das, Parth Sarthi Sen Gupta, Saroj Kumar Panda, et al.
Journal of Biomolecular Structure & Dynamics|May 6, 2021
<i>In-silico</i> evidences on filarial cystatin as a putative ligand of human TLR4Nabarun Chandra Das, Parth Sarthi Sen Gupta, Satyaranjan Biswal, et al.
Pageof 2